M. Better

发表

Cysteine analogs of recombinant barley ribosome inactivating protein form antibody conjugates with enhanced stability and potency in vitro.

S. Carroll, D. Fishwild, S. L. Bernhard, 1994, Bioconjugate chemistry.

Activity of recombinant mitogillin and mitogillin immunoconjugates.

S. Carroll, D. Fishwild, S. L. Bernhard, 1992, The Journal of biological chemistry.

Gelonin analogs with engineered cysteine residues form antibody immunoconjugates with unique properties.

A. Kung, S. Carroll, D. Fishwild, 1994, The Journal of biological chemistry.

Site-specific DNA condensation and pairing mediated by the int protein of bacteriophage lambda.

H. Echols, C. Lu, R. Williams, 1982, Proceedings of the National Academy of Sciences of the United States of America.

Role of the Xis protein of bacteriophage λ in a specific reactive complex at the attR prophage attachment site

H. Echols, S. Wickner, M. Better, 1983, Cell.

Studies on the association of E. coli phage λ DNA and the host chromosome: Lack of a role of membranes

M. Better, D. Freifelder, 1982 .

A Rapid Cell Expansion Process for Production of Engineered Autologous CAR-T Cell Therapies.

S. Rosenberg, S. Feldman, J. Kochenderfer, 2016, Human gene therapy methods.

Axicabtagene ciloleucel, a first-in-class CAR T cell therapy for aggressive NHL

A. Ribas, M. Roberts, A. Bot, 2018, Leukemia & lymphoma.

Efficacy of anti-CD5 F(ab')2 and Fab' immunoconjugates in human peripheral blood lymphocyte-reconstituted severe combined immunodeficient mice.

F. Kohn, A. Kung, D. Fishwild, 1993, International journal of immunopharmacology.

Preferential T-cell receptor beta-chain variable gene use in myelin basic protein-reactive T-cell clones from patients with multiple sclerosis.

G. Nedwin, A. Vandenbark, H. Offner, 1991, Proceedings of the National Academy of Sciences of the United States of America.

Production of antifungal recombinant peptides in Escherichia coli.

M. Better, P. Gavit, 2000, Journal of biotechnology.

Studies on the replication of Escherichia coli phage lambda DNA. I. The kinetics of DNA replication and requirements for the generation of rolling circles.

M. Better, D. Freifelder, 1983, Virology.

Isolation and characterization of the recA gene of Rhizobium meliloti

D. Helinski, M. Better, 1983, Journal of bacteriology.

Momordin II, a ribosome inactivating protein from Momordica balsamina, is homologous to other plant proteins.

M. Better, M. Ortigão, 1992, Nucleic acids research.

Chimeric mouse-human anti-carcinoma antibodies that mediate different anti-tumor cell biological activities.

R. R. Robinson, M. Better, A. Horwitz, 1991, Human antibodies and hybridomas.

Tumor burden, inflammation, and product attributes determine outcomes of axicabtagene ciloleucel in large B-cell lymphoma.

D. Miklos, C. Jacobson, L. Lekakis, 2020, Blood advances.

Secretion of functional antibody and Fab fragment from yeast cells.

R. R. Robinson, K. Hellstrom, M. Better, 1988, Proceedings of the National Academy of Sciences of the United States of America.

Cloning and expression of a gene encoding gelonin, a ribosome-inactivating protein from Gelonium multiflorum.

M. Better, D. Garrison, P. Nolan, 1993, Gene.

4 – araB EXPRESSION SYSTEM IN Escherichia coli

M. Better, 1999 .

T‐Cell‐Targeted Immunofusion Proteins from E. coli

M. Better, 1996, Annals of the New York Academy of Sciences.

T Cell-targeted Immunofusion Proteins from Escherichia coli(*)

A. Kung, S. Carroll, D. Fishwild, 1995, The Journal of Biological Chemistry.

Chimeric immunoglobulin light chains are secreted at different levels: influence of framework-1 amino acids.

M. Better, F. Preugschat, A. Horwitz, 1994, Molecular immunology.

287. Production of KTE-C19 (Anti-CD19 CAR T Cells) for ZUMA-1: A Phase 1/2 Multi-Center Study Evaluating Safety and Efficacy in Subjects with Refractory Aggressive Non-Hodgkin Lymphoma (NHL)

J. Rossi, A. Bot, L. Navale, 2016 .

Electron-microscopic examination of the binding of a large RNA polymerase III transcription factor to a tRNA gene.

D. Stillman, E. Geiduschek, M. Better, 1985, Journal of molecular biology.

Structural relationships among rhizobium meliloti symbiotic promoters

G. Ditta, D. Helinski, D. Corbin, 1983, Cell.

Escherichia coli secretion of an active chimeric antibody fragment.

R. R. Robinson, M. Better, A. Horwitz, 1988, Science.

Deletion analysis of Rhizobium meliloti symbiotic promoters

G. Ditta, D. Helinski, M. Better, 1985, The EMBO journal.

Expression of engineered antibodies and antibody fragments in microorganisms.

M. Better, A. Horwitz, 1989, Methods in enzymology.

The role of specialized nucleoprotein structures in site-specific recombination and initiation of DNA replication.

H. Echols, M. Better, R. McMacken, 1984, Cold Spring Harbor symposia on quantitative biology.

Potent anti-CD5 ricin A chain immunoconjugates from bacterially produced Fab' and F(ab')2.

S. Carroll, D. Fishwild, S. L. Bernhard, 1993, Proceedings of the National Academy of Sciences of the United States of America.

Overcoming Challenges for Engineered Autologous T Cell Therapies

M. Sabatino, M. Better, V. Chiruvolu, 2018 .

Human-engineered monoclonal antibodies retain full specific binding activity by preserving non-CDR complementarity-modulating residues.

G. Studnicka, M. Better, R. Williams, 1994, Protein engineering.

Role of the Xis protein of bacteriophage lambda in a specific reactive complex at the attR prophage attachment site.

H. Echols, S. Wickner, M. Better, 1983, Cell.

Dialysis of small samples in agarose gels.

M. Better, D. Freifelder, 1982, Analytical biochemistry.

In Vivo Expression of Correctly Folded Antibody Fragments from Microorganisms

M. Better, A. Horwitz, 1993 .